Almac Group, the global contract development and manufacturing organisation has announced the appointment of Dr Victor Diaz Perez as Head of Physical Sciences.
He will be responsible for Almac’s Solid State Chemistry and Physical Sciences business and tasked with strengthening the overarching chemical development strategy.
Before joining Almac, Dr Diaz spent 10 years with Pharmorphix, now part of Johnson Matthey, a global CRO providing solid state services for the pharmaceutical and fine chemicals industry.
There he worked as Projects Director before being appointed as Site Manager/Operations Director. He was also a key player in the acquisition of Pharmorphix by Johnson Matthey from Sigma Aldrich, which completed in October 2015.
Before joining Pharmorphix, Dr Diaz worked for more than 7 years as a Medicinal Chemist at Medivir AB, both within the hit identification and lead optimisation teams and, prior to that, he worked at High Force Research, providing chemical synthesis and R&D service to the pharmaceutical, agrochemical and fine chemical industries.
John Robson, VP Quality Operations at Almac Sciences, commented on Dr Diaz’s appointment: 'Victor’s combined experience within physical sciences and his extensive knowledge of strategic management makes him a valuable addition to our team. We are delighted he has accepted this role with Almac and we look forward to working together to continue to develop our global business and provide best in class, innovative drug development solutions to our growing client base.'
Victor has a PhD in organic chemistry from the University of Seville working on the design, synthesis and evaluation of glycomimetics of natural occurring azasugars used for the inhibition of glycosidases. He has also been awarded CChem status and recognition as a Fellow of the Royal Society of Chemistry.